Abstract:BACKGROUND: The repair of large bone defects remains challenging for orthopaedic surgeons. Bone grafting remains the method of choice; such grafts fill spaces and enhance bone repair. Therapeutic agents also aid bone healing. The objective of this study is to develop a composite bioactive scaffold composed of polylactide-coglycolide (PLGA) and tricalcium phosphate (TCP) (the basic carrier) incorporating osteogenic, bioactive magnesium metal powder (Mg).METHOD: Porous PLGA/TCP scaffolds incorporating Mg were fabricated using a low-temperature rapid-prototyping process. We term the PLGA/TCP/Mg porous scaffold (hereafter, PPS). PLGA/TCP lacking Mg served as the control material when evaluating the efficacy of PPS. A total of 36 New Zealand white rabbits were randomly divided into blank, PLGA/TCP (P/T) and PPS group, with 12 rabbits in each group. We established bone defects 15 mm in length in rabbit radii to evaluate the in vivo osteogenic potential of the bioactive scaffold in terms of the direct controlled release of osteogenic Mg ion during in vivo scaffold degradation. Radiographs of the operated radii were taken immediately after implantation and then at 2, 4, 8 and 12 weeks. Micro-computed tomography of new bone formation and remaining scaffold and histological analysis were performed at 4, 8, 12 weeks after operation.RESULTS: X-ray imaging performed at weeks 4, 8 and 12 post-surgery revealed more newly formed bone within defects implanted with PPS and PLGA/TCP scaffolds than blank group (p < 0.05). And micro-computed tomography performed at weeks 4 and 8 after surgery revealed more newly formed bone within defects implanted with PPS scaffolds than PLGA/TCP scaffolds (p < 0.05). Histologically, the PPS group had more newly mineralized bone than controls (p < 0.05). The increases in new bone areas (total implant regions) in the PPS and PLGA/TCP groups were 19.42% and 5.67% at week 4 and 48.23% and 28.93% at week 8, respectively. The percentages of remaining scaffold material in total implant regions in the PPS and PLGA/TCP groups were 53.30% and 7.65% at week 8 and 20.52% and 2.70% at week 12, respectively.CONCLUSION: Our new PPS composite scaffold may be an excellent orthopaedic substitute; it exhibits good biocompatibility and may potentially have clinical utility.TRANSLATIONAL POTENTIAL OF THIS ARTICLE: Magnesium and beta-tricalcium phosphate had osteoinduction. It is significant to print a novel bone composite scaffold with osteoinduction to repair segmental bone defects. This study evaluated efficacy of PPS in the rabbit radius segmental bone defect model. The results showed that the novel scaffold with good biocompatibility may be an excellent graft and potentially have clinical utility.

Preparation and Osteogenic Properties of Magnesium Calcium Phosphate Biocement Scaffolds for Bone Regeneration

3D robocasting magnesium-doped wollastonite/TCP bioceramic scaffolds with improved bone regeneration capacity in critical sized calvarial defects

Preparationand Characterization of Macroporous Magnesium Phosphate Scaffold for Bone Regeneration

3D Printing Magnesium-Doped Wollastonite/β-Tcp Bioceramics Scaffolds with High Strength and Adjustable Degradation

The Outstanding Mechanical Response and Bone Regeneration Capacity of Robocast Dilute Magnesium-Doped Wollastonite Scaffolds in Critical Size Bone Defects.

Osteogenic evaluation of calcium/magnesium-doped mesoporous silica scaffold with incorporation of rhBMP-2 by synchrotron radiation-based μCT.

Mechanically Strong Porous Bioceramic Tubes Facilitate Large Segmental Bone Defect Repair by Providing Long-Term Structurally Stability and Promoting Osteogenesis

A Biodegradable Magnesium Phosphate Cement Incorporating Chitosan and Rhbmp-2 Designed for Bone Defect Repair

Hierarchically microporous/macroporous scaffold of magnesium-calcium phosphate for bone tissue regeneration.

3D POROUS COMPOSITE SCAFFOLDS WITH HIGH CALCIUM PHOSPHATE CONTENT AND ADDITION OF INORGANIC IONS FOR BONE REGENERATION APPLICATIONS

A PLA-tPU Based Magnesium Ion Incorporated CSH/nHA Bioactive Porous Composite Scaffold for Critical Bone Defect Repair

Development of Magnesium Calcium Phosphate Biocement for Bone Regeneration

Biocompatible octacalcium phosphate/sodium alginate/silk fibroin composite scaffolds for bone regeneration

Macroporous Biphasic Calcium Phosphate Scaffolds Reinforced by Poly-L-lactic Acid/hydroxyapatite Nanocomposite Coatings for Bone Regeneration

Magnesium-alloy rods reinforced bioglass bone cement composite scaffolds with cortical bone-matching mechanical properties and excellent osteoconductivity for load-bearing bone in vivo regeneration

Characterization And Cytocompatibility Of Biphasic Calcium Phosphate/Polyamide 6 Scaffolds For Bone Regeneration

PLA–tPU based magnesium ion incorporated CSH/nHA bioactive porous composite scaffold for critical bone defect repair

Osteogenic magnesium incorporated into PLGA/TCP porous scaffold by 3D printing for repairing challenging bone defect

DLP printed β-tricalcium phosphate functionalized ceramic scaffolds promoted angiogenesis and osteogenesis in long bone defects

Use of a three-dimensional printed polylactide-coglycolide/tricalcium phosphate composite scaffold incorporating magnesium powder to enhance bone defect repair in rabbits

RhBMP-2 Loaded 3D-Printed Mesoporous Silica/calcium Phosphate Cement Porous Scaffolds with Enhanced Vascularization and Osteogenesis Properties